Overview

Dose-Range Finding Study for MK0893 (0893-008)

Status:
Terminated
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
A study to compare MK0893 to metformin or placebo for patients with Type 2 diabetes (Diabetes Mellitus).
Phase:
Phase 2
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Metformin